SCOPIA CAPITAL MANAGEMENT LP - Q2 2016 holdings

$4.84 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 43 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 39.0% .

 Value Shares↓ Weighting
SPR SellSPIRIT AEROSYSTEMS HLDGS INC$549,224,000
-14.2%
12,772,652
-9.5%
11.34%
-5.0%
UTHR BuyUNITED THERAPEUTICS CORP DEL$455,599,000
-3.1%
4,301,352
+1.9%
9.41%
+7.3%
FCEA SellFOREST CITY RLTY TR INC$401,293,000
+2.8%
17,987,140
-2.8%
8.29%
+13.8%
BIDU SellBAIDU INCspon adr rep a$354,998,000
-20.8%
2,149,550
-8.5%
7.33%
-12.3%
ITRI BuyITRON INC$192,876,000
+3.3%
4,475,084
+0.0%
3.98%
+14.4%
SABR BuySABRE CORP$183,718,000
+3.4%
6,857,699
+11.6%
3.79%
+14.5%
JD BuyJD COM INCspon adr cl a$181,583,000
+19.5%
8,553,118
+49.1%
3.75%
+32.3%
IWM SellISHARES TRput$179,748,000
-7.2%
1,563,300
-10.7%
3.71%
+2.7%
DST BuyDST SYS INC DEL$179,416,000
+6.3%
1,540,979
+3.0%
3.70%
+17.7%
PRGO BuyPERRIGO CO PLC$177,847,000
+429.1%
1,961,477
+646.5%
3.67%
+485.6%
NFLX BuyNETFLIX INC$172,722,000
-8.5%
1,888,086
+2.3%
3.57%
+1.3%
MYGN SellMYRIAD GENETICS INC$142,422,000
-29.6%
4,654,327
-13.9%
2.94%
-22.0%
FICO BuyFAIR ISAAC CORP$135,906,000
+8.9%
1,202,599
+2.2%
2.81%
+20.5%
GWPH NewGW PHARMACEUTICALS PLCads$135,314,0001,477,709
+100.0%
2.79%
CNMD BuyCONMED CORP$132,405,000
+32.6%
2,774,045
+16.5%
2.73%
+46.9%
SPY SellSPDR S&P 500 ETF TRput$129,078,000
-52.5%
616,200
-53.4%
2.66%
-47.4%
SERV NewSERVICEMASTER GLOBAL HLDGS I$122,243,0003,071,422
+100.0%
2.52%
INSYQ BuyINSYS THERAPEUTICS INC NEW$116,296,000
-18.4%
8,987,313
+0.8%
2.40%
-9.6%
JCI NewJOHNSON CTLS INC$113,461,0002,563,521
+100.0%
2.34%
IBKR SellINTERACTIVE BROKERS GROUP IN$99,269,000
-28.6%
2,804,202
-20.7%
2.05%
-21.0%
ZBRA NewZEBRA TECHNOLOGIES CORPcl a$94,663,0001,889,480
+100.0%
1.96%
ACOR BuyACORDA THERAPEUTICS INC$80,882,000
+15.2%
3,171,229
+19.4%
1.67%
+27.5%
RTRX BuyRETROPHIN INC$67,889,000
+38.1%
3,811,821
+5.9%
1.40%
+53.1%
WMB NewWILLIAMS COS INC DEL$58,391,0002,699,540
+100.0%
1.21%
SellNEURODERM LTD$54,980,000
+15.1%
3,383,358
-0.0%
1.14%
+27.4%
MLCO SellMELCO CROWN ENTMT LTDadr$44,412,000
-78.9%
3,530,382
-72.3%
0.92%
-76.6%
BA  BOEING CO$39,601,000
+2.3%
304,9270.0%0.82%
+13.3%
O NewREALTY INCOME CORPput$35,533,000512,300
+100.0%
0.73%
GNRC  GENERAC HLDGS INC$33,402,000
-6.1%
955,4450.0%0.69%
+4.1%
LUK SellLEUCADIA NATL CORP$25,405,000
-76.1%
1,465,958
-77.7%
0.52%
-73.5%
PRGO NewPERRIGO CO PLCcall$25,152,000277,400
+100.0%
0.52%
BCO SellBRINKS CO$21,487,000
-84.0%
754,195
-81.1%
0.44%
-82.2%
TRN BuyTRINITY INDS INC$19,093,000
+75.7%
1,028,162
+73.2%
0.39%
+94.1%
AAAP SellADVANCED ACCELERATOR APPLICsponsored ads$16,959,000
-53.6%
560,907
-46.3%
0.35%
-48.7%
BNCL SellBENEFICIAL BANCORP INC$15,905,000
-79.2%
1,250,417
-77.6%
0.33%
-77.0%
GBX NewGREENBRIER COS INC$13,516,000463,992
+100.0%
0.28%
FOSL  FOSSIL GROUP INC$11,296,000
-35.8%
395,9250.0%0.23%
-29.0%
SLCA  U S SILICA HLDGS INC$8,580,000
+51.7%
248,9110.0%0.18%
+68.6%
AEGR  AEGERION PHARMACEUTICALS INC$8,498,000
-59.7%
5,703,5870.0%0.18%
-55.5%
MNKD NewMANNKIND CORP$5,701,0004,914,641
+100.0%
0.12%
INTEQ SellINTELSAT S A$5,193,000
-17.6%
2,012,760
-19.5%
0.11%
-8.5%
PSEC SellPROSPECT CAPITAL CORPORATION$815,000
-30.9%
104,194
-35.8%
0.02%
-22.7%
AMSC  AMERICAN SUPERCONDUCTOR CORP$166,000
+11.4%
19,6100.0%0.00%0.0%
CRVS ExitCORVUS PHARMACEUTICALS INC$0-213,550
-100.0%
-0.06%
LNTH ExitLANTHEUS HLDGS INC$0-1,824,344
-100.0%
-0.06%
RLYP ExitRELYPSA INC$0-363,810
-100.0%
-0.09%
CABO ExitCABLE ONE INC$0-46,837
-100.0%
-0.38%
M ExitMACYS INC$0-2,417,969
-100.0%
-1.99%
MDVN ExitMEDIVATION INC$0-2,804,911
-100.0%
-2.40%
HUN ExitHUNTSMAN CORP$0-14,807,467
-100.0%
-3.67%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC39Q4 202228.3%
SPDR S&P 500 ETF TR31Q3 202316.9%
ISHARES TR28Q3 202310.9%
MANNKIND CORP24Q3 20230.5%
BAIDU INC21Q2 20188.6%
ITRON INC21Q3 202012.1%
RETROPHIN INC20Q3 20204.5%
HARMONIC INC19Q3 202310.5%
JOHNSON CTLS INTL PLC17Q3 20209.6%
ACORDA THERAPEUTICS INC17Q3 20194.0%

View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.

Latest significant ownerships (13-D/G)
SCOPIA CAPITAL MANAGEMENT LP Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
VERRA MOBILITY CorpOctober 28, 20226,710,0744.4%
Spirit AeroSystems Holdings, Inc.February 14, 20222,084,2122.0%
Retrophin, Inc.February 14, 20202,011,6974.7%
Horizon Therapeutics Public Ltd CoJanuary 10, 20202,527,4561.4%
ZOGENIX, INC.January 10, 2020919,4842.1%
ITRON, INC.January 07, 20201,808,0594.6%
ACORDA THERAPEUTICS INCSold outNovember 12, 201900.0%
LA JOLLA PHARMACEUTICAL COApril 10, 2019480,0001.8%
Prothena Corp plcMarch 11, 20191,883,8164.7%
GW PHARMACEUTICALS PLCFebruary 14, 20191,345,1984.6%

View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D2024-04-26
13F-HR2024-02-14
SC 13G2024-02-14
SC 13D/A2024-01-22
13F-HR/A2023-11-14
13F-HR2023-11-14
SC 13D2023-09-21
13F-HR2023-08-14
13F-HR2023-05-15
SC 13D/A2023-04-12

View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.

Compare quarters

Export SCOPIA CAPITAL MANAGEMENT LP's holdings